GlycoRoads: A platform for the de novo design of glycans

GlycoRoads aims to develop an AI-driven platform for de novo glycan design using molecular dynamics simulations to create a comprehensive database, enhancing customization for therapeutic and material applications.

Subsidie
€ 150.000
2025

Projectdetails

Introduction

In the spirit of the various in silico de novo protein design products, GlycoRoads aims to introduce the world's first tool for de novo glycan design. Our cutting-edge screening platform will harness the power of molecular dynamics (MD) simulations to analyze hundreds of thousands of glycan structures, extracting crucial structural information to populate a comprehensive database (DB).

Database Development

This rich repository of data will serve as the foundation for an AI-driven user interface, designed to interrogate the DB and guide the de novo design of glycans that can adopt specific target conformations, greatly accelerating the exploration of their applications.

Importance of Glycans

The growing recognition of glycans' critical roles in biology and materials science underscores the transformative potential of our project. If successful, it will unlock unprecedented capabilities to customize glycans for targeted applications, opening new avenues in the design of next-generation therapeutics and materials.

Project Foundation

Within the ERC GlycoFold grant, our team has designed glycans with precise secondary structures. GlycoRoads builds on this groundwork to make the strategic design of glycans accessible to both academic and industrial researchers.

Objectives

This goal requires the completion of three critical objectives:

  1. Enhancing the current MD-based screening platform.
  2. Generating and systematically cataloging a vast array of data into a comprehensive and accessible DB.
  3. Developing an AI tool to leverage the DB to accelerate the design of glycans for diverse applications.

Anticipated Outcomes

The anticipated outcomes of our project—a detailed DB of glycan structures and a user-friendly interface for its interrogation—offer substantial commercialization prospects. Together, they pave the way for a groundbreaking shift in de novo glycan design across various fields.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-6-2025
Einddatum30-11-2026
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution

Glyco13Cell aims to chemically remodel cell surface glycans using NMR probes to enhance understanding of glycan-lectin interactions for developing novel tools in infectious disease treatment.

€ 1.500.000
ERC Starting...

Glycan foldamers: designing oligosaccharides to build three-dimensional architectures

The project aims to develop synthetic carbohydrate foldamers that adopt defined structures and assemble into complex architectures, enhancing understanding and applications in chemistry and material science.

€ 1.499.956
ERC Starting...

Imaging Single Glycoconjugates

GlycoX develops single molecule imaging methods to elucidate glycoconjugate structures, enhancing understanding for therapeutics and diagnostics in immune response and microbial infection.

€ 2.000.000
ERC Consolid...

Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infection

GLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment.

€ 1.994.024
ERC Proof of...

Glyco-protein arrays for functional virus surveillance

This project aims to assess the feasibility of glycan-protein arrays for early detection of pandemic influenza and coronavirus threats, enhancing public health surveillance.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Inhibitor-Mediated Programming of Glycoforms

The project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions.

€ 2.998.878
EIC Transition

Precision control of glycosylation to open a new era of therapeutic antibodies

GlycoBoost aims to revolutionize monoclonal antibody design by producing therapeutics with uniform N-glycans, enhancing safety and efficacy for autoimmune disease treatments.

€ 2.499.540
EIC Pathfinder

Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseases

The project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications.

€ 3.920.718
EIC Pathfinder

Universal GPCR Activity Sensor for Next Generation Drug Discovery

This project aims to develop a novel single-assay technology platform for GPCR drug discovery, enhancing detection and classification of drug candidates to improve efficacy and reduce failures.

€ 2.965.384
EIC Transition

TraffikGene-Tx: Targeted Peptide Carriers for RNA Delivery

TraffikGene-Tx aims to develop safe, scalable peptide carriers for targeted RNA delivery, addressing genetic diseases and enhancing NAT therapies to improve patient outcomes and reduce healthcare costs.

€ 2.498.963